Related references
Note: Only part of the references are listed.Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation
Camilla Ottesen et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2022)
Surgical strategy for medication-related osteonecrosis of the jaw (MRONJ) on maxilla: A multicenter retrospective study
Kohei Okuyama et al.
JOURNAL OF DENTAL SCIENCES (2021)
Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients
Sakiko Soutome et al.
SCIENTIFIC REPORTS (2021)
Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review
Leonzio Fortunato et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2020)
A Drug Holiday Reduces the Frequency and Severity of Medication-Related Osteonecrosis of the Jaw in a Minipig Model
Sven Otto et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis
Alvaro Limones et al.
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL (2020)
Efficacy of a high-dose antiresorptive drug holiday to reduce the risk of medication-related osteonecrosis of the jaw (MRONJ): A systematic review
Camilla Ottesen et al.
HELIYON (2020)
Medication-related osteonecrosis of the jaw after tooth extraction in cancer patients: a multicenter retrospective study
T. Hasegawa et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Risk factors for medication-related osteonecrosis of the jaws: A systematic review
K. McGowan et al.
ORAL DISEASES (2018)
Numb chin syndrome: A reflection of malignancy or a harbinger of MRONJ? A multicenter experience
Leonzio Fortunato et al.
JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY (2018)
Factors affecting development of medication-related osteonecrosis of the jaw in cancer patients receiving high-dose bisphosphonate or denosumab therapy: Is tooth extraction a risk factor?
Sakiko Soutome et al.
PLOS ONE (2018)
Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw
J. Chang et al.
CURRENT OSTEOPOROSIS REPORTS (2018)
Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw
Toshiyuki Yoneda et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2017)
A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ?
T. Hasegawa et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Denosumab-related osteonecrosis of the jaw in a patient with bone metastases of prostate cancer: A case report and literature review
Hitoshi Yoshimura et al.
ONCOLOGY LETTERS (2017)
Medication-Related Osteonecrosis of the Jaw: New Insights into Molecular Mechanisms and Cellular Therapeutic Approaches
Thomas Lombard et al.
STEM CELLS INTERNATIONAL (2016)
Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
Fengxia Chen et al.
ONCOLOGY RESEARCH AND TREATMENT (2016)
Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Sven Otto et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2015)
Pathophysiology of Osteonecrosis of the Jaws
Tara Aghaloo et al.
ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA (2015)
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw-2014 Update
Salvatore L. Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2014)
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems
Gerry Oster et al.
SUPPORTIVE CARE IN CANCER (2013)
Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
Allan Lipton et al.
EUROPEAN JOURNAL OF CANCER (2012)
Tooth extraction in patients on zoledronic acid therapy
Marco Mozzati et al.
ORAL ONCOLOGY (2012)
Denosumab and bisphosphonates: Different mechanisms of action and effects
Roland Baron et al.
BONE (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Konstantinos Vahtsevanos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The Pathogenesis of Bisphosphonate-Related Osteonecrosis of the Jaw: So Many Hypotheses, So Few Data
Matthew R. Allen et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates
Ana O. Hoff et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients
Athanassios Kyrgidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy
R. G. G. Russell et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Treatment strategies for skeletal complications of cancer
James R. Berenson et al.
CANCER BIOLOGY & THERAPY (2006)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
RE Marx
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
Share Paper
